Breaking News Instant updates and real-time market news.

TSLA

Tesla

$227.99

-0.74 (-0.32%)

, GOOG

Alphabet

$1,240.00

105.66 (9.31%)

16:22
07/28/19
07/28
16:22
07/28/19
16:22

Musk says Tesla cars may soon stream Netflix, YouTube when not moving

Using his Twitter account, Tesla (TSLA) CEO Elon Musk said that, "Ability to stream YouTube [GOOGL] & Netflix [NFLX] when car is stopped coming to your Tesla soon! Has an amazingly immersive, cinematic feel due to the comfy seats & surround sound audio. [...] When full self-driving is approved by regulators, we will enable video while moving." Reference Link

TSLA

Tesla

$227.99

-0.74 (-0.32%)

GOOG

Alphabet

$1,240.00

105.66 (9.31%)

GOOGL

Alphabet Class A

$1,236.00

99.31 (8.74%)

NFLX

Netflix

$336.00

9.46 (2.90%)

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 27

    Oct

TSLA Tesla
$227.99

-0.74 (-0.32%)

07/25/19
ROTH
07/25/19
NO CHANGE
Target $224
ROTH
Neutral
Tesla price target lowered to $224 from $238 at Roth Capital
Roth Capital analyst Craig Irwin lowered his price target for Tesla to $224 form $238 after the company posted weak Q2 EPS, with automotive margins marking the lowest levels since Q1 of 2018. The analyst reiterates a Neutral rating on the shares.
07/25/19
FBCO
07/25/19
NO CHANGE
Target $189
FBCO
Underperform
Tesla to be challenged to meet delivery guidance, says Credit Suisse
Credit Suisse analyst Dan Levy notes that Tesla posted a Q2 EPS miss. Broadly, while Tesla has maintained its narrative, the analyst expects the stock to be under pressure near-term, as expectations had risen post the Q2 deliveries release earlier this month. Levy reiterates an Underperform rating and $189 price target on the shares as the Q2 results reminded him of the challenges ahead for Tesla in gross margin, especially as it relates to Models S/X. While Tesla has maintained its delivery guidance, he believes the company will be challenged to meet it given challenges to S/X volumes and the phase-out of the U.S. EV tax credit.
07/25/19
NEED
07/25/19
NO CHANGE
NEED
Underperform
Needham cautious on Tesla's second half goals
Needham analyst Rajvindra Gill kept his Underperform rating on Tesla after its "significant" loss reported in Q2 along with a "slight" increase in its margins hurt by average selling price reductions across all of its vehicle models. The analyst notes that while the company affirmed its FY19 delivery target and forecast profitability in Q4, he is cautious on that outlook as it would require a "significant snapback" in the second half of the year. Gill sees Tesla remaining challenged by "structurally low margins" and growing competition.
07/25/19
WEDB
07/25/19
NO CHANGE
Target $220
WEDB
Neutral
Tesla price target lowered to $220 from $230 at Wedbush
Wedbush analyst Daniel Ives lowered his price target for Tesla to $220 from $230 to reflect a softer margin profile and pushed out profitability looking ahead. The analyst notes that the company delivered some bad news that will weigh on shares on Thursday as the company significantly missed the Street on the bottom line with "disappointing" gross margins that fundamentally call into question its ability to show sustainable profitability on the heels of lower margin Model 3 units going forward. Ives reiterates a Neutral rating on the shares.
GOOG Alphabet
$1,240.00

105.66 (9.31%)

07/26/19
JEFF
07/26/19
NO CHANGE
Target $1500
JEFF
Buy
Alphabet price target raised to $1,500 from $1,450 at Jefferies
Jefferies analyst Brent Thill raised his price target for Alphabet (GOOGL) to $1,500 from $1,450 saying the company's Q2 results Q2 "bounced from Q1's dip." The rebound was broad-based across geographies and major segments, Thill tells investors in a research note. He believes Alphabet's valuation remains attractive and reiterates a Buy rating on the shares.
07/26/19
MSCO
07/26/19
NO CHANGE
Target $1450
MSCO
Overweight
Alphabet price target raised to $1,450 from $1,400 at Morgan Stanley
Morgan Stanley analyst Brian Nowak raised his price target on Alphabet shares to $1,450 from $1,400 after the company reported what he identified as its third largest acceleration in four years. The company's continued use of machine learning and innovation drove a roughly 150 basis points sequential acceleration in ex-FX Websites growth, noted Nowak, who estimates that the largest driver of the acceleration was mobile search. The analyst, who sees a favorable set-up for Alphabet's ability to drive faster than expected growth given that he thinks its product pipeline for Google Websites is "robust" heading into the second half and 2020, keeps an Overweight rating on the stock.
07/26/19
FBCO
07/26/19
NO CHANGE
Target $1500
FBCO
Outperform
Alphabet price target raised to $1,500 from $1,400 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for Alphabet to $1,500 from $1,400 and maintained an Outperform rating following the company's "clean" second quarter report. In a research note to investors, Ju says that while he was preparing to wait until the first quarter of 2020 to see possibilities for revenue growth acceleration, the narrative now shifts from fears of ongoing deceleration to possibilities of incremental ad budget share capture as the company turns on monetization of its Discover feed and other new products recently announced at Marketing Live 2019 gain adoption.
07/26/19
SUSQ
07/26/19
NO CHANGE
Target $1550
SUSQ
Positive
Alphabet price target raised to $1,550 from $1,500 at Susquehanna
Susquehanna analyst Shyam Patil raised the price target on Alphabet shares to $1,550 following the company's "strong" Q2 and "very confident outlook commentary." The secular ad growth story, driven by mobile search and YouTube, is also being paired with better expense management and more shareholder-friendly capital returns, said Patil, who keeps a Positive rating on Alphabet shares.
GOOGL Alphabet Class A
$1,236.00

99.31 (8.74%)

07/26/19
KEYB
07/26/19
NO CHANGE
Target $1516
KEYB
Overweight
Alphabet price target raised to $1,516 from $1,430 at KeyBanc
KeyBanc analyst Andy Hargreaves reiterated an Overweight rating on Alphabet and raised his price target to $1,516 from $1,430 following the company's "very good" second quarter results. In a research note to investors, Hargreaves says results showed stability in core Sites ad revenue and likely acceleration in GCP, which along with other significant growth opportunities suggest the potential for solid revenue and profit growth for the foreseeable future.
07/26/19
RBCM
07/26/19
NO CHANGE
Target $1425
RBCM
Outperform
Alphabet price target raised to $1,425 from $1,300 at RBC Capital
RBC Capital analyst Mark Mahaney raised his price target on Alphabet to $1,425 and kept his Outperform rating after its better than expected Q2 results that followed a "softer" Q1. The analyst attributes the strength to the company's "Three Horsemen" of growth, Mobile Search, Cloud, and YouTube, contending that the trajectory for Alphabet remains "intact". Mahaney further cites Alphabet's record-high stock buyback in the quarter at $3.6B and the announcement of a new $25B authorization.
07/26/19
WEDB
07/26/19
NO CHANGE
Target $1500
WEDB
Outperform
Alphabet price target raised to $1,500 from $1,350 at Wedbush
Wedbush analyst Michael Pachter raised his price target for Alphabet to $1,500 from $1,350 and said an Outperform rating is "warranted" given valuation upside an an "unrivaled" collection of high-profile core platforms and products. In a research note to investors, Pachter says he expects revenues and profit to continue to grow for the foreseeable future following a "solid" top-line performance in the second quarter that surpassed estimates.
NFLX Netflix
$336.00

9.46 (2.90%)

07/18/19
MSCO
07/18/19
NO CHANGE
Target $450
MSCO
Overweight
Morgan Stanley offers reasons 'not to overreact' to Netflix subscriber miss
Morgan Stanley analyst Benjamin Swinburne offered several "arguments not to overreact" to Netflix's Q2 subscriber miss, beginning by noting that the company has missed its quarterly net additions forecast once a year in each of the last three years. In all three of these cases, the company has outperformed meaningfully the following quarter, he pointed out and in two cases the miss came in the seasonally light second quarter. Additionally, the magnitude of this miss relative to the size of the business is similar to prior misses, said Swinburne, who contends that Netflix's ability to forecast has not meaningfully changed. The analyst, whose full year net additions, revenue and earnings estimates are largely unchanged following last night's report, keeps an Overweight rating and $450 price target on Netflix shares.
07/19/19
NEED
07/19/19
NO CHANGE
NEED
Hold
Netflix sub losses are the 'new normal', says Needham
Needham analyst Laura Martin keeps her Hold rating on Netflix (NFLX) after its Q2 net subscriber adds missed expectations with a loss of 130K U.S. subs, saying her survey of subscribers to glean the cause of churn suggests that losses may be the "new normal" for the company. The analyst notes that the churn has been linked to the "relative perceived content quality" each month with SVOD services being "not additive", as evidenced by 12% of Netflix's subscribers responding that they turned off their service to watch Game of Thrones in Q2. Martin adds that the launch of Disney+ (DIS) priced at $5.83 per month with a 1-year contract will hurt Netflix's U.S. subs unless it can also discount its service.
07/18/19
ADAM
07/18/19
NO CHANGE
Target $415
ADAM
Buy
Netflix subscriber weakness likely temporary, says Canaccord
Canaccord analyst Michael Graham noted Netflix reported mixed results as the subscriber net additions missed guidance and his estimates, but revenue growth accelerated for the second straight quarter, and Q3 subscriber growth should accelerate on international strength. The analyst said the subscriber miss may weigh on the shares but he still sees a strong content strategy and room to add large numbers of international subscriptions going forward. Graham reiterated his Buy rating and $415 price target on Netflix shares.
07/18/19
WBLR
07/18/19
NO CHANGE
WBLR
Outperform
Netflix fundamentals unchanged after Q2 subscriber miss, says William Blair
In three of the last four second quarters, including last night, Netflix has missed subscriber guidance, William Blair analyst Ralph Schackart tells investors in a research note. In 2016 and 2018, misses in Q2 were both followed by "strong beats" to the tune of 1M subscribers in Q3, added the analyst. Further, he notes that management said Q3 of 2019 was off to a strong start in terms of subscriber additions, attributable to Stranger Things. Schackart believes Netflix's fundamentals have not changed as the company "continues its march into streamed TV." From here, the analyst sees roughly 18% share upside over the next 12 months using a long-term earnings valuation framework, which models compounded earnings growth of 34% through 2025 and a multiple of 26 times forward earnings. He forecasts 298M global subscribers at year-end 2025, and a stock price of roughly a $621 stock by 2024, with a discounted value today of roughly $378. Schackart keeps an Outperform rating on Netflix shares.

TODAY'S FREE FLY STORIES

ETNB

89bio

$26.03

3.03 (13.17%)

, YAYO

YayYo

$3.65

-0.29 (-7.36%)

11:09
11/17/19
11/17
11:09
11/17/19
11:09
On The Fly
Opening Day: 89bio has strong opening week »

89bio (ETNB) finished its…

ETNB

89bio

$26.03

3.03 (13.17%)

YAYO

YayYo

$3.65

-0.29 (-7.36%)

CAN

Canaan

$0.00

(0.00%)

SITM

SiTime

$0.00

(0.00%)

BABA

Alibaba

$185.44

2.75 (1.51%)

YXR

YX Asset Recovery

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

WFC

Wells Fargo

$53.80

0.3 (0.56%)

, AAPL

Apple

$265.73

3.07 (1.17%)

10:01
11/16/19
11/16
10:01
11/16/19
10:01
Periodicals
Berkshire Hathaway inactive with record cash hoard, Barron's says »

Berkshire Hathaway…

WFC

Wells Fargo

$53.80

0.3 (0.56%)

AAPL

Apple

$265.73

3.07 (1.17%)

OXY

Occidental Petroleum

$38.94

1.18 (3.13%)

BRK.B

Berkshire Hathaway

$219.74

0.38 (0.17%)

BRK.A

Berkshire Hathaway

$329,361.11

266.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

DIS

Disney

$144.63

-2.56 (-1.74%)

09:43
11/16/19
11/16
09:43
11/16/19
09:43
Periodicals
Disney+ may not be able to hold onto huge number of subs, Barron's says »

While Disney's (DIS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$112.11

2.9 (2.66%)

09:27
11/16/19
11/16
09:27
11/16/19
09:27
Periodicals
Medtronic shares 'could rise even more,' Barron's says »

Barron's recommended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BR

Broadridge

$119.80

0.485 (0.41%)

09:18
11/16/19
11/16
09:18
11/16/19
09:18
Periodicals
Broadridge a defensive name that can withstand slowdown, Barron's says »

Broadridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$193.95

-0.02 (-0.01%)

, MDT

Medtronic

$112.11

2.9 (2.66%)

09:07
11/16/19
11/16
09:07
11/16/19
09:07
Periodicals
Barron's suggests dividend stocks for retirement savers »

In this week's…

MCD

McDonald's

$193.95

-0.02 (-0.01%)

MDT

Medtronic

$112.11

2.9 (2.66%)

KO

Coca-Cola

$52.67

0.03 (0.06%)

PRU

Prudential

$93.61

0.82 (0.88%)

SYF

Synchrony

$37.05

0.34 (0.93%)

KEY

KeyCorp

$18.96

0.1 (0.53%)

T

AT&T

$39.49

0.53 (1.36%)

AMGN

Amgen

$220.84

2.29 (1.05%)

CSCO

Cisco

$45.10

0.18 (0.40%)

RCL

Royal Caribbean

$117.91

2.69 (2.33%)

MRK

Merck

$84.89

0.33 (0.39%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

JPM

JPMorgan

$129.51

0.83 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 02

    Dec

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 14

    Jan

  • 21

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 14

    Mar

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

, MSFT

Microsoft

$149.95

1.89 (1.28%)

08:54
11/16/19
11/16
08:54
11/16/19
08:54
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

AAPL

Apple

$265.73

3.07 (1.17%)

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

THC

Tenet

$30.55

1.08 (3.66%)

GM

General Motors

$36.87

0.07 (0.19%)

FCAU

Fiat Chrysler

$16.02

0.04 (0.25%)

TM

Toyota

$144.29

1.16 (0.81%)

F

Ford

$8.96

0.16 (1.82%)

HMC

Honda

$28.99

0.155 (0.54%)

VWAGY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 04

    Feb

  • 06

    Feb

MDCO

The Medicines Co.

$51.92

1.03 (2.02%)

04:55
11/16/19
11/16
04:55
11/16/19
04:55
Conference/Events
Roth Capital pharmaceuticals analysts to hold a luncheon »

Analysts host Dr. John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

CVET

Covetrus

$14.93

1.44 (10.67%)

18:41
11/15/19
11/15
18:41
11/15/19
18:41
Hot Stocks
Covetrus CEO: We're a leader in the humanization of pets »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.54

-0.93 (-2.05%)

18:02
11/15/19
11/15
18:02
11/15/19
18:02
Hot Stocks
Viacom extends cable deal for 'The Office' through 2025 »

Viacom (VIA) announced…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.54

-0.93 (-2.05%)

VIAB

Viacom

$23.07

0.59 (2.62%)

VIA

Viacom

$26.59

1.28 (5.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CWK

Cushman & Wakefield

$19.10

0.1 (0.53%)

17:48
11/15/19
11/15
17:48
11/15/19
17:48
Hot Stocks
Cushman & Wakefield CEO sells 84.6K share of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LMT

Lockheed Martin

$393.52

3.305 (0.85%)

17:39
11/15/19
11/15
17:39
11/15/19
17:39
Hot Stocks
Lockheed Martin awarded maximum $3.33B Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESCA

Escalade

$10.90

-0.09 (-0.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Escalade CEO Fetherman to retire »

Escalade announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.96

0.1 (0.78%)

, ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Eldorado, Caesars stockholders approve Eldorado acquisition of Caesars »

Eldorado Resorts (ERI)…

CZR

Caesars

$12.96

0.1 (0.78%)

ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EGRX

Eagle Pharmaceuticals

$57.24

0.55 (0.97%)

17:15
11/15/19
11/15
17:15
11/15/19
17:15
Syndicate
Breaking Syndicate news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$60.82

0.84 (1.40%)

17:11
11/15/19
11/15
17:11
11/15/19
17:11
Hot Stocks
Fabrinet President Gill sells 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEUM

Pareteum

$0.38

-0.0209 (-5.21%)

17:05
11/15/19
11/15
17:05
11/15/19
17:05
Hot Stocks
Pareteum receives noncompliance notice from Nasdaq »

Pareteum announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

Hexo

$1.78

-0.1 (-5.32%)

17:00
11/15/19
11/15
17:00
11/15/19
17:00
Hot Stocks
Hexo was cannabis was being grown in unlicensed space at Niagara site »

HEXO Corp provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$220.84

2.29 (1.05%)

, CELG

Celgene

$110.02

-0.01 (-0.01%)

16:57
11/15/19
11/15
16:57
11/15/19
16:57
Hot Stocks
Bristol-Myers gets FTC clearance for Celgene acquisition »

Bristol-Myers Squibb…

AMGN

Amgen

$220.84

2.29 (1.05%)

CELG

Celgene

$110.02

-0.01 (-0.01%)

BMY

Bristol-Myers

$58.61

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

RAVE

Rave Restaurant

$1.44

-0.79 (-35.43%)

16:47
11/15/19
11/15
16:47
11/15/19
16:47
Hot Stocks
BBRC Asset Management reports 6.6% passive stake in Rave Restaurant »

BBRC Asset Management …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHAP

Chaparral Energy

$0.89

-0.0521 (-5.52%)

16:46
11/15/19
11/15
16:46
11/15/19
16:46
Hot Stocks
Chaparral Energy receives continued listing standard notice from NYSE »

Chaparral Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

CI

Cigna

$196.08

6.41 (3.38%)

, CNC

Centene

$57.57

2.91 (5.32%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks closed out the…

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

NVDA

Nvidia

$204.12

-5.76 (-2.74%)

AMZN

Amazon.com

$1,739.33

-15.38 (-0.88%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

UAA

Under Armour

$17.78

0.65 (3.79%)

UA

Under Armour

$15.97

0.41 (2.64%)

AMRN

Amarin

$23.99

2.5 (11.63%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

GOOG

Alphabet

$1,334.01

21.82 (1.66%)

GOOGL

Alphabet Class A

$1,333.33

23.54 (1.80%)

ORCL

Oracle

$56.43

0.33 (0.59%)

RH

RH

$188.73

13.535 (7.73%)

QGEN

Qiagen

$40.56

3.255 (8.73%)

FTCH

Farfetch

$9.66

2.17 (28.97%)

THC

Tenet

$30.55

1.08 (3.66%)

TORC

resTORbio

$1.10

-6.83 (-86.13%)

ACB

Aurora Cannabis

$2.72

-0.57 (-17.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 28

    Dec

  • 06

    Jan

  • 21

    Jan

  • 06

    Feb

NYT

New York Times

$31.60

0.44 (1.41%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
New York Times CEO sells 66,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.